Cargando…

β-Dystroglycan Restoration and Pathology Progression in the Dystrophic mdx Mouse: Outcome and Implication of a Clinically Oriented Study with a Novel Oral Dasatinib Formulation

ROS-activated cSrc tyrosine kinase (TK) promotes the degradation of β-dystroglycan (β-DG), a dystrophin-glycoprotein complex component, which may reinforce damaging signals in Duchenne muscular dystrophy (DMD). Therefore, cSrc-TK represents a promising therapeutic target. In mdx mice, a 4-week subcu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mantuano, Paola, Boccanegra, Brigida, Conte, Elena, De Bellis, Michela, Cirmi, Santa, Sanarica, Francesca, Cappellari, Ornella, Arduino, Ilaria, Cutrignelli, Annalisa, Lopedota, Angela Assunta, Mele, Antonietta, Denora, Nunzio, De Luca, Annamaria
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8615430/ https://www.ncbi.nlm.nih.gov/pubmed/34827740 http://dx.doi.org/10.3390/biom11111742

Ejemplares similares

Dasatinib/HP-β-CD Inclusion Complex Based Aqueous Formulation as a Promising Tool for the Treatment of Paediatric Neuromuscular Disorders
por: Cutrignelli, Annalisa, et al.
Publicado: (2019)

Growth hormone secretagogues modulate inflammation and fibrosis in mdx mouse model of Duchenne muscular dystrophy
por: Boccanegra, Brigida, et al.
Publicado: (2023)

Branched-Chain Amino Acids and Di-Alanine Supplementation in Aged Mice: A Translational Study on Sarcopenia
por: Mantuano, Paola, et al.
Publicado: (2023)

Ultrasonography validation for early alteration of diaphragm echodensity and function in the mdx mouse model of Duchenne muscular dystrophy
por: Mele, Antonietta, et al.
Publicado: (2021)

Ergogenic Effect of BCAAs and L-Alanine Supplementation: Proof-of-Concept Study in a Murine Model of Physiological Exercise
por: Mantuano, Paola, et al.
Publicado: (2020)

Plectin 1f scaffolding at the sarcolemma of dystrophic (mdx) muscle fibers through multiple interactions with β-dystroglycan
por: Rezniczek, Günther A., et al.
Publicado: (2007)

Exploring the Microfluidic Production of Biomimetic Hybrid Nanoparticles and Their Pharmaceutical Applications
por: Fondaj, Dafina, et al.
Publicado: (2023)

Circadian Genes as Exploratory Biomarkers in DMD: Results From Both the mdx Mouse Model and Patients
por: Rossi, Rachele, et al.
Publicado: (2021)

Preclinical Ultrasonography in Rodent Models of Neuromuscular Disorders: The State of the Art for Diagnostic and Therapeutic Applications
por: Mele, Antonietta, et al.
Publicado: (2023)

LKB1 signaling is altered in skeletal muscle of a Duchenne muscular dystrophy mouse model
por: Boccanegra, Brigida, et al.
Publicado: (2023)

Transferrin Functionalized Liposomes Loading Dopamine HCl: Development and Permeability Studies across an In Vitro Model of Human Blood–Brain Barrier
por: Lopalco, Antonio, et al.
Publicado: (2018)

Stability data of extemporaneous suspensions of hydroxychloroquine sulphate in oral liquid bases after tablet manipulation
por: Perrone, Mara, et al.
Publicado: (2020)

Direct cyclodextrin-based powder extrusion 3D printing for one-step production of the BCS class II model drug niclosamide
por: Pistone, Monica, et al.
Publicado: (2022)

The hydroxypropyl‐β‐cyclodextrin‐minoxidil inclusion complex improves the cardiovascular and proliferative adverse effects of minoxidil in male rats: Implications in the treatment of alopecia
por: Maqoud, Fatima, et al.
Publicado: (2020)

TSPO Ligand-Methotrexate Prodrug Conjugates: Design, Synthesis, and Biological Evaluation
por: Laquintana, Valentino, et al.
Publicado: (2016)

Decrease in Prosaposin in the Dystrophic mdx Mouse Brain
por: Gao, Hui-ling, et al.
Publicado: (2013)

Proteome Profiling of the Dystrophic mdx Mice Diaphragm
por: Mucha, Olga, et al.
Publicado: (2023)

Bcr-Abl Tyrosine Kinase Inhibitors in the Treatment of Pediatric CML
por: Carofiglio, Francesca, et al.
Publicado: (2020)

Safety issues and harmful pharmacological interactions of nutritional supplements in Duchenne muscular dystrophy: considerations for Standard of Care and emerging virus outbreaks
por: Boccanegra, Brigida, et al.
Publicado: (2020)

Hormonal Receptors in Skeletal Muscles of Dystrophic Mdx Mice
por: Feder, David, et al.
Publicado: (2013)

Erythropoietin reduces the expression of myostatin in mdx dystrophic mice
por: Feder, D., et al.
Publicado: (2014)

Development of Rabbit Monoclonal Antibodies for Detection of Alpha-Dystroglycan in Normal and Dystrophic Tissue
por: Fortunato, Marisa J., et al.
Publicado: (2014)

Macrophages fine tune satellite cell fate in dystrophic skeletal muscle of mdx mice
por: Madaro, Luca, et al.
Publicado: (2019)

Mutation Types and Aging Differently Affect Revertant Fiber Expansion in Dystrophic Mdx and Mdx52 Mice
por: Echigoya, Yusuke, et al.
Publicado: (2013)

Dysfunctional Muscle and Liver Glycogen Metabolism in mdx Dystrophic Mice
por: Stapleton, David I., et al.
Publicado: (2014)

Dystrophic phenotype improvement in the diaphragm muscle of mdx mice by diacerhein
por: Mâncio, Rafael Dias, et al.
Publicado: (2017)

Data on protein abundance alteration induced by chronic exercise in mdx mice model of Duchenne muscular dystrophy and potential modulation by apocynin and taurine
por: Gamberi, Tania, et al.
Publicado: (2018)

Extensive but Coordinated Reorganization of the Membrane Skeleton in Myofibers of Dystrophic (mdx) Mice
por: Williams, McRae W., et al.
Publicado: (1999)

A proteasome inhibitor fails to attenuate dystrophic pathology in mdx mice
por: Selsby, Joshua, et al.
Publicado: (2012)

The FVB Background Does Not Dramatically Alter the Dystrophic Phenotype of Mdx Mice
por: Wasala, Nalinda B., et al.
Publicado: (2015)

Increased levels of interleukin-6 exacerbate the dystrophic phenotype in mdx mice
por: Pelosi, Laura, et al.
Publicado: (2015)

Lipidomic Analyses Reveal Specific Alterations of Phosphatidylcholine in Dystrophic Mdx Muscle
por: Valentine, William J., et al.
Publicado: (2022)

Investigating the Potential for Sulforaphane to Attenuate Gastrointestinal Dysfunction in mdx Dystrophic Mice
por: Swiderski, Kristy, et al.
Publicado: (2021)

Chronic Dosing with Membrane Sealant Poloxamer 188 NF Improves Respiratory Dysfunction in Dystrophic Mdx and Mdx/Utrophin(-/-) Mice
por: Markham, Bruce E., et al.
Publicado: (2015)

The Small Leucine-Rich Repeat Proteoglycan Biglycan Binds to α-Dystroglycan and Is Upregulated in Dystrophic Muscle
por: Bowe, Mark A., et al.
Publicado: (2000)

ISPD Overexpression Enhances Ribitol-Induced Glycosylation of α-Dystroglycan in Dystrophic FKRP Mutant Mice
por: Cataldi, Marcela P., et al.
Publicado: (2019)

Digital Technologies Applied to Control the One-Step Process of Cannabis Olive Oil Preparations
por: Bongiorno, Paolo, et al.
Publicado: (2023)

Dystrophic Changes in Extraocular Muscles after Gamma Irradiation in mdx:utrophin(+/−) Mice
por: McDonald, Abby A., et al.
Publicado: (2014)

Subproteomic profiling of sarcolemma from dystrophic mdx-4cv skeletal muscle
por: Murphy, Sandra, et al.
Publicado: (2018)

Cardioprotective Effect of Whole Body Periodic Acceleration in Dystrophic Phenotype mdx Rodent
por: Uryash, Arkady, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_m9hp1tjdfoc5q5rbchgonac4fu